Based on the high expression of eIF4G2 and PTBP1 in cancer tissues, Feng and colleagues developed a circular RNA therapeutic that contains Human rhinovirus type 2 (HRV2) IRES to achieve selective translation in cancer cells overexpressing these factors [127]. The gene discussed is EIF4G2; the disease is cancer.